Therapeutic applications of ribozymes /

Saved in:
Bibliographic Details
Imprint:Totowa, N.J. : Humana Press, ©1998.
Description:1 online resource (xiv, 462 pages) : illustrations
Language:English
Series:Methods in molecular medicine ; 11
Methods in molecular medicine ; 11.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11129146
Hidden Bibliographic Details
Other authors / contributors:Scanlon, Kevin J., 1947-
ISBN:9781592595952
1592595952
0896034771
9780896034778
Notes:Includes bibliographical references and index.
Restrictions unspecified
Electronic reproduction. [Place of publication not identified] : HathiTrust Digital Library, 2010.
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212
English.
digitized 2010 HathiTrust Digital Library committed to preserve
Print version record.
Summary:In Therapeutic Applications of Ribozymes, expert laboratory scientists describe in detail their methodologies for constructing ribozymes designed to elucidate the role of specific genes as key routes to the development of novel therapies for a wide variety of diseases. The authors review the many sites targeted with ribozymes in various diseases and provide specific accounts of the practical techniques required for the proper use of ribozymes in these systems. Their cutting-edge protocols demonstrate how to achieve ribozyme expression in distinct cellular systems, the preparation and use of high-efficiency ribozyme DNA or RNA delivery, and the studies required to prove the efficacy of ribozyme-mediated inhibition, with its concomitant effect on phenotypic parameters. Therapeutic Applications of Ribozymes contains all the practical detail necessary to realize the high promise of ribozyme technology as a significant, widely used methodology. Focused on ribozyme targets and the novel associated technology, the book immediately becomes the leading resource for all those seeking to transform this new category of therapeutic agent into efficacious clinical practice.
Other form:Print version: Therapeutic applications of ribozymes. Totowa, N.J. : Humana Press, ©1998 0896034771
Standard no.:10.1385/0896034771.

MARC

LEADER 00000cam a2200000Ma 4500
001 11129146
006 m o d
007 cr cnu|||uuuuu
008 980415s1998 njua ob 001 0 eng d
005 20240705145204.3
019 |a 272404510  |a 320971450  |a 606990778  |a 647695345  |a 771202811  |a 964913080  |a 967613744  |a 990412848  |a 994720384  |a 1005804424  |a 1058397025  |a 1078064072  |a 1078826334  |a 1078872150  |a 1081204377  |a 1087339034  |a 1097276380  |a 1109319974  |a 1120839826  |a 1164871005  |a 1166132759  |a 1170368121  |a 1171333735  |a 1179895079  |a 1203528771  |a 1228574528 
020 |a 9781592595952  |q (Springer e-ISBN) 
020 |a 1592595952  |q (Springer e-ISBN) 
020 |z 0896034771 
020 |z 9780896034778 
024 7 |a 10.1385/0896034771.  |2 doi 
035 |a (OCoLC)55698103  |z (OCoLC)272404510  |z (OCoLC)320971450  |z (OCoLC)606990778  |z (OCoLC)647695345  |z (OCoLC)771202811  |z (OCoLC)964913080  |z (OCoLC)967613744  |z (OCoLC)990412848  |z (OCoLC)994720384  |z (OCoLC)1005804424  |z (OCoLC)1058397025  |z (OCoLC)1078064072  |z (OCoLC)1078826334  |z (OCoLC)1078872150  |z (OCoLC)1081204377  |z (OCoLC)1087339034  |z (OCoLC)1097276380  |z (OCoLC)1109319974  |z (OCoLC)1120839826  |z (OCoLC)1164871005  |z (OCoLC)1166132759  |z (OCoLC)1170368121  |z (OCoLC)1171333735  |z (OCoLC)1179895079  |z (OCoLC)1203528771  |z (OCoLC)1228574528 
035 9 |a (OCLCCM-CC)55698103 
040 |a YUS  |b eng  |e pn  |c YUS  |d OCLCQ  |d BAKER  |d OCLCG  |d DAY  |d CUV  |d CNTRU  |d GW5XE  |d OCLCQ  |d CUS  |d E7B  |d OCLCQ  |d OCLCE  |d OCLCO  |d OCLCF  |d OCL  |d OCLCQ  |d OCLCO  |d YDXCP  |d OCLCQ  |d EUW  |d EBLCP  |d OCLCQ  |d OCL  |d OCLCQ  |d VT2  |d OCLCA  |d LIP  |d MERER  |d OTZ  |d OCLCQ  |d STF  |d TFH  |d OCLCO  |d OCLCA  |d BUF  |d OCLCO  |d CRU  |d OCLCQ  |d U3W  |d OCLCQ  |d AU@  |d OCLCO  |d OCLCQ  |d YOU  |d CANPU  |d OCLCQ  |d OCLCO  |d U3G  |d OCLCO  |d OCLCQ  |d HS0  |d WURST  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d UWK  |d OCLCQ 
042 |a dlr 
049 |a MAIN 
050 4 |a RM666.R554  |b T47 1998 
060 4 |a QU 58.7 T398 1998 
072 0 |a X300 
072 7 |a PSF.  |2 bicssc 
072 7 |a SCI049000.  |2 bisacsh 
084 |a 35.74  |2 bcl 
084 |a 35.75  |2 bcl 
245 0 0 |a Therapeutic applications of ribozymes /  |c edited by Kevin J. Scanlon. 
260 |a Totowa, N.J. :  |b Humana Press,  |c ©1998. 
300 |a 1 online resource (xiv, 462 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Methods in molecular medicine ;  |v 11 
504 |a Includes bibliographical references and index. 
505 0 |a Small efficient hammerhead ribozymes -- The hairpin ribozyme: discovery and development for gene therapy -- Molecular manipulations of the catalytic RNAs from the human hepatitis delta virus -- The design, production, and validation of an anti-HIV type 1 ribozyme -- Methods for Treating HIV by Gene therapy using ribozymes -- An expression vector for multiple ribozymes -- Viral RNA targets for ribozymes: influenza A virus -- Hammerhead ribozyme-mediated cleavage of hepatitis B virus RNA -- Bovine leukemia virus ribozymes -- Use of ribozymes to specifically alter the MDR-1 phenotype -- Adenoviral-mediated anti-H-ras ribozyme for the treatment of bladder cancer -- Tissue-specific delivery of an anti-H-ras ribozyme against malignant melanoma -- Ribozymes as a novel approach for the treatment of human pancreatic carcinoma -- K-ras ribozyme for lung cancer -- Anti-c-erb-B-2 Ribozyme for breast cancer -- Ribozymes: applications in cancer metastasis research -- Preformed ribozymes: Strategies for design and in vivo application as anticytokine agents -- Folate-polylysine-mediated delivery of a multiunit anti-BCR/ABL ribozyme to BCR/ABL-transformed 32D cells -- Ribozymes targeted against AML1/MTG8: evaluation of ribozyme efficiency in a cell-free system and transfection with cationic liposome -- Ribozyme targeting of the growth factor pleiotrophin -- Ribozyme-mediated inhibition of cell proliferation: a model for identifying and refining a therapeutic ribozyme -- Inhibition of 13APP synthesis by ribozymes and oligonucleotides in a coupled reticulocyte transcription translation system -- Selective modification of fatty acid synthesis pathway by expression of an acetyI-CoA carboxylase-specific ribozyme gene -- In vivo knockout of a tissue-specific gene by synthetic ribozymes -- Ribozyme-mediated downregulation of gene expression in transgenic mice -- Targeted cleavage of RNA using external guide sequences and eukaryotic RNase P -- A PCR-based approach to hammerhead ribozyme synthesis-- PCR-based approach to hammerhead ribozyme synthesis -- Measurement of ribozyme activity using RNase protection. 
588 0 |a Print version record. 
506 |3 Use copy  |f Restrictions unspecified  |2 star  |5 MiAaHDL 
533 |a Electronic reproduction.  |b [Place of publication not identified] :  |c HathiTrust Digital Library,  |d 2010.  |5 MiAaHDL 
538 |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.  |u http://purl.oclc.org/DLF/benchrepro0212  |5 MiAaHDL 
583 1 |a digitized  |c 2010  |h HathiTrust Digital Library  |l committed to preserve  |2 pda  |5 MiAaHDL 
546 |a English. 
520 |a In Therapeutic Applications of Ribozymes, expert laboratory scientists describe in detail their methodologies for constructing ribozymes designed to elucidate the role of specific genes as key routes to the development of novel therapies for a wide variety of diseases. The authors review the many sites targeted with ribozymes in various diseases and provide specific accounts of the practical techniques required for the proper use of ribozymes in these systems. Their cutting-edge protocols demonstrate how to achieve ribozyme expression in distinct cellular systems, the preparation and use of high-efficiency ribozyme DNA or RNA delivery, and the studies required to prove the efficacy of ribozyme-mediated inhibition, with its concomitant effect on phenotypic parameters. Therapeutic Applications of Ribozymes contains all the practical detail necessary to realize the high promise of ribozyme technology as a significant, widely used methodology. Focused on ribozyme targets and the novel associated technology, the book immediately becomes the leading resource for all those seeking to transform this new category of therapeutic agent into efficacious clinical practice. 
650 0 |a Catalytic RNA  |x Therapeutic use. 
650 0 |a Catalytic RNA  |v Laboratory manuals. 
650 2 |a Genetic Therapy. 
650 2 |a Methods. 
650 2 |a RNA, Catalytic. 
650 2 |a Investigative Techniques 
650 2 |a RNA, Untranslated. 
650 2 |a Genetic Engineering. 
650 2 |a Biological Therapy. 
650 2 |a Enzymes. 
650 2 |a Enzymes and Coenzymes 
650 2 |a RNA. 
650 2 |a Genetic Techniques. 
650 2 |a Therapeutics. 
650 2 |a Analytical, Diagnostic and Therapeutic Techniques and Equipment 
650 2 |a Nucleic Acids. 
650 2 |a Chemicals and Drugs 
650 2 |a Nucleic Acids, Nucleotides, and Nucleosides 
650 7 |a Catalytic RNA.  |2 fast  |0 (OCoLC)fst00848887 
650 7 |a Catalytic RNA  |x Therapeutic use.  |2 fast  |0 (OCoLC)fst00848888 
650 1 7 |a Ribozymes.  |2 gtt 
650 1 7 |a Therapeutische werking.  |2 gtt 
650 1 7 |a Wetenschappelijke technieken.  |2 gtt 
653 0 0 |a ribozymen 
653 0 0 |a ribozymes 
653 0 0 |a geneesmiddelenbehandeling 
653 0 0 |a drug therapy 
653 1 0 |a Pharmacology 
653 1 0 |a Farmacologie 
655 4 |a Electronic books. 
655 7 |a Laboratory manuals.  |2 fast  |0 (OCoLC)fst01920776 
700 1 |a Scanlon, Kevin J.,  |d 1947-  |0 http://id.loc.gov/authorities/names/n95803425 
776 0 8 |i Print version:  |t Therapeutic applications of ribozymes.  |d Totowa, N.J. : Humana Press, ©1998  |z 0896034771  |w (DLC) 98021526  |w (OCoLC)39013764 
830 0 |a Methods in molecular medicine ;  |v 11.  |x 1543-1894  |0 http://id.loc.gov/authorities/names/n88525800 
903 |a HeVa 
929 |a oclccm 
999 f f |i ce680ffd-9e6e-5a13-98f8-2568e6605841  |s 465d4a3d-d364-5e4d-b972-10c740e80599 
928 |t Library of Congress classification  |a RM666.R554 T47 1998  |l Online  |c UC-FullText  |u https://link.springer.com/10.1385/0896034771  |z Springer Nature  |g ebooks  |i 12530700